DocSym
β
Searchsearch
Search
(Y44.4) Antithrombotic drugs [platelet-aggregation inhibitors]
More details coming soon
178 229 in individuals diagnosis antithrombotic drugs [platelet-aggregation inhibitors] confirmed
15 706 deaths with diagnosis antithrombotic drugs [platelet-aggregation inhibitors]
9% mortality rate associated with the disease antithrombotic drugs [platelet-aggregation inhibitors]
Diagnosis antithrombotic drugs [platelet-aggregation inhibitors] is diagnosed Women are 11.62% more likely than Men
78 763
Men receive the diagnosis antithrombotic drugs [platelet-aggregation inhibitors]
8 102 (10.3 %)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
99 466
Women receive the diagnosis antithrombotic drugs [platelet-aggregation inhibitors]
7 604 (7.6 %)Died from this diagnosis.
Risk Group for the Disease antithrombotic drugs [platelet-aggregation inhibitors] - Men aged 75-79 and Women aged 80-84
In Men diagnosis is most often set at age 0-5, 15-19, 25-34, 40-94
Less common in men the disease occurs at Age 0-1, 5-14, 20-24, 35-39, 95+Less common in women the disease occurs at Age 5-29, 40-49, 95+
In Women diagnosis is most often set at age 0-5, 30-39, 50-94
Disease Features antithrombotic drugs [platelet-aggregation inhibitors]
Absence or low individual and public risk
Antithrombotic drugs [platelet-aggregation inhibitors] - what does this mean
Antithrombotic drugs, also known as platelet-aggregation inhibitors, work by preventing the formation of blood clots by inhibiting platelet aggregation. they work by blocking the activity of enzymes involved in the clotting process, preventing platelets from sticking together and forming clots. these drugs can be used to prevent and treat conditions such as deep vein thrombosis, stroke, and heart attack.
What happens during the disease - antithrombotic drugs [platelet-aggregation inhibitors]
Antithrombotic drugs, or platelet-aggregation inhibitors, work by blocking the action of certain enzymes that activate platelets and cause them to stick together and form clots. this prevents the formation of clots, which can lead to dangerous conditions such as deep vein thrombosis, pulmonary embolism, and stroke. by preventing the formation of clots, these drugs can help reduce the risk of these conditions.
Clinical Pattern
More details coming soon
How does a doctor diagnose
More details coming soon
Treatment and Medical Assistance
More details coming soon
17 Days of Hospitalization Required
Average Time for Outpatient Care Not Established
Antithrombotic drugs [platelet-aggregation inhibitors] - Prevention
Antithrombotic drugs are medications that can be used to prevent the formation of blood clots. these drugs work by inhibiting platelet aggregation, which is the process by which platelets stick together and form clots. as a result, they can be used to help prevent strokes, heart attacks, and other serious cardiovascular events. regular use of antithrombotic drugs can help reduce the risk of these conditions and improve overall heart health.